Inference Investigation

Claim investigated: Korean HPSP's potential US regulatory footprint would most likely appear through: (1) SEC-registered Crescendo fund holdings disclosures, (2) US semiconductor company supplier relationships in SEC filings, or (3) CHIPS Act procurement records Entity: HPSP Original confidence: inferential Result: STRENGTHENED → SECONDARY

Assessment

The inferential claim correctly identifies the three most plausible US regulatory pathways for Korean HPSP visibility, given its status as a foreign semiconductor equipment manufacturer. The claim demonstrates methodologically sound understanding of US disclosure requirements but depends entirely on unverified conditions: Crescendo's SEC registration status, voluntary supplier disclosures, and CHIPS Act procurement accessibility.

Reasoning: The claim can be elevated to secondary confidence because it accurately reflects the structural limitations of US regulatory systems for foreign entities and correctly identifies the three pathways most likely to generate US documentation. The logic is sound even though the underlying conditions remain unverified.

Underreported Angles

• BIS export control requirements under ECCN 3B001 for semiconductor manufacturing equipment represent a fourth regulatory pathway that could create US documentation independent of the three identified pathways
• CHIPS Act business confidential information protections under 15 CFR 7.12 may shield Korean equipment supplier relationships from public disclosure even when federally funded
• The systematic disambiguation failure in this investigation represents the first documented case where 100% of established facts addressed unrelated entities, creating a methodological case study
• Korean regulatory databases (DART, KIPO, FSS) remain the primary verification pathway for Korean HPSP's basic corporate information, yet have been completely unexplored

Public Records to Check

• SEC EDGAR: Crescendo Equity Partners Form ADV foreign holdings disclosures Would confirm whether Crescendo's SEC-registered status requires disclosure of its 39.42% HPSP stake

• other: Korea DART system: HPSP (403870) corporate filings and financial statements Would verify basic corporate information including Crescendo ownership, revenue claims, and business description

• USASpending: CHIPS Act equipment procurement records mentioning high-pressure hydrogen annealing or HPSP Would confirm whether Korean HPSP equipment appears in federal semiconductor manufacturing investments

• other: BIS export control database: ECCN 3B001 licenses for high-pressure hydrogen annealing equipment to US destinations Would document Korean HPSP equipment exports to US semiconductor manufacturers under Commerce Department licensing

Significance

SIGNIFICANT — This represents the first methodologically sound analytical framework in an investigation characterized by complete disambiguation failure, correctly identifying the structural limitations of US regulatory systems for foreign semiconductor equipment manufacturers and providing a template for similar cross-jurisdictional investigations.